- Home
- LVLU vs BGLC Comparison
LVLU vs BGLC Comparison
Compare LVLU & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- BGLC
- Stock Information
- Founded
- LVLU 1996
- BGLC 2017
- Country
- LVLU United States
- BGLC Malaysia
- Employees
- LVLU N/A
- BGLC N/A
- Industry
- LVLU Catalog/Specialty Distribution
- BGLC Medical Specialities
- Sector
- LVLU Consumer Discretionary
- BGLC Health Care
- Exchange
- LVLU Nasdaq
- BGLC Nasdaq
- Market Cap
- LVLU 10.8M
- BGLC 10.4M
- IPO Year
- LVLU 2021
- BGLC N/A
- Fundamental
- Price
- LVLU $3.95
- BGLC $5.04
- Analyst Decision
- LVLU Hold
- BGLC
- Analyst Count
- LVLU 1
- BGLC 0
- Target Price
- LVLU $15.00
- BGLC N/A
- AVG Volume (30 Days)
- LVLU 40.0K
- BGLC 54.1K
- Earning Date
- LVLU 08-13-2025
- BGLC 08-18-2025
- Dividend Yield
- LVLU N/A
- BGLC N/A
- EPS Growth
- LVLU N/A
- BGLC N/A
- EPS
- LVLU N/A
- BGLC N/A
- Revenue
- LVLU $292,337,000.00
- BGLC $9,551,559.00
- Revenue This Year
- LVLU N/A
- BGLC N/A
- Revenue Next Year
- LVLU $2.53
- BGLC N/A
- P/E Ratio
- LVLU N/A
- BGLC N/A
- Revenue Growth
- LVLU N/A
- BGLC 4.01
- 52 Week Low
- LVLU $2.98
- BGLC $2.01
- 52 Week High
- LVLU $28.05
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- LVLU 47.01
- BGLC 42.79
- Support Level
- LVLU $3.67
- BGLC $5.45
- Resistance Level
- LVLU $4.70
- BGLC $5.79
- Average True Range (ATR)
- LVLU 0.35
- BGLC 0.21
- MACD
- LVLU -0.00
- BGLC -0.06
- Stochastic Oscillator
- LVLU 26.80
- BGLC 4.94
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.